Health Statistics in Kuwait

Explore trusted health data and trends for Kuwait.

All Health datasets for Kuwait (711)

Dataset
Prevalence of cervical cancer screening among women aged 30-49 years (%)
WHO
–
Physical activity among adolescents, mean active days per week
WHO
0%
Physical activity among adolescents, no active days in the past week, prevalence (%)
WHO
0%
Physical activity among adolescents, active on all 7 days of the past week, prevalence (%)
WHO
0%
Crude suicide rates (per 100 000 population)
WHO
–
Age-standardized suicide rates (per 100 000 population)
WHO
+9.4%
Mortality rate attributed to unintentional poisoning (per 100 000 population)
WHO
0%
Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths
WHO
+1.9%
Age-standardized NCD mortality rate (per 100 000 population)
WHO
−12.1%
Total NCD Deaths
WHO
+0.5%
Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
WHO
−11.1%
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
WHO
−7.3%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, female (% of female population ages 0-4)
Gender Statistics
0%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, male (% of male population ages 0-4)
Gender Statistics
+0.3%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4 (% of population ages 0-4)
Gender Statistics
+0.1%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, female (% of female population ages 5-14)
Gender Statistics
−22.9%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, male (% of male population ages 5-14)
Gender Statistics
+4.3%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14 (% of population ages 5-14)
Gender Statistics
−9.2%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, female (% of female population ages 15-59)
Gender Statistics
−3.6%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, male (% of male population ages 15-59)
Gender Statistics
+10.8%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59 (% of population ages 15-59)
Gender Statistics
+9.6%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, female (% of female population ages 60+)
Gender Statistics
−14%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, male (% of male population ages 60+)
Gender Statistics
+5.4%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+ (% of population ages 60+)
Gender Statistics
+3.5%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, female (% of female population)
Gender Statistics
−9.8%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, male (% of male population)
Gender Statistics
+8.6%
Cause of death, by injury, ages 0-4, female (% of female population ages 0-4)
Gender Statistics
−10.1%
Cause of death, by injury, ages 0-4, male (% of male population ages 0-4)
Gender Statistics
−13.2%
Cause of death, by injury, ages 0-4 (% of population ages 0-4)
Gender Statistics
−11.9%
Cause of death, by injury, ages 5-14, female (% of female population ages 5-14)
Gender Statistics
+20.9%
Cause of death, by injury, ages 5-14, male (% of male population ages 5-14)
Gender Statistics
−6.6%
Cause of death, by injury, ages 5-14 (% of population ages 5-14)
Gender Statistics
+2.6%
Cause of death, by injury, ages 15-59, female (% of female population ages 15-59)
Gender Statistics
+11.3%
Cause of death, by injury, ages 15-59, male (% of male population ages 15-59)
Gender Statistics
+5.9%
Cause of death, by injury, ages 15-59 (% of population ages 15-59)
Gender Statistics
+3.4%
Cause of death, by injury, ages 60+, female (% of female population ages 60+)
Gender Statistics
−8.8%
Cause of death, by injury, ages 60+, male (% of male population ages 60+)
Gender Statistics
−15.6%
Cause of death, by injury, ages 60+ (% of population ages 60+)
Gender Statistics
−21.3%
Cause of death, by injury, female (% of female population)
Gender Statistics
−0.7%
Cause of death, by injury, male (% of male population)
Gender Statistics
+8.8%
Cause of death, by non-communicable diseases, ages 0-4, female (% of female population ages 0-4)
Gender Statistics
+1%
Cause of death, by non-communicable diseases, ages 0-4, male (% of male population ages 0-4)
Gender Statistics
+1.3%
Cause of death, by non-communicable diseases, ages 0-4 (% of population ages 0-4)
Gender Statistics
+1.2%
Cause of death, by non-communicable diseases, ages 5-14, female (% of female population ages 5-14)
Gender Statistics
−2.4%
Cause of death, by non-communicable diseases, ages 5-14, male (% of male population ages 5-14)
Gender Statistics
+1.8%
Cause of death, by non-communicable diseases, ages 5-14 (% of population ages 5-14)
Gender Statistics
+0.1%
Cause of death, by non-communicable diseases, ages 15-59, female (% of female population ages 15-59)
Gender Statistics
−4.6%
Cause of death, by non-communicable diseases, ages 15-59, male (% of male population ages 15-59)
Gender Statistics
−7.8%
Cause of death, by non-communicable diseases, ages 15-59 (% of population ages 15-59)
Gender Statistics
−8.6%
Cause of death, by non-communicable diseases, ages 60+, female (% of female population ages 60+)
Gender Statistics
+6.5%
Cause of death, by non-communicable diseases, ages 60+, male (% of male population ages 60+)
Gender Statistics
−3.4%
Cause of death, by non-communicable diseases, ages 60+ (% of population ages 60+)
Gender Statistics
−2.7%
Cause of death, by non-communicable diseases, female (% of female population)
Gender Statistics
+4.7%
Cause of death, by non-communicable diseases, male (% of male population)
Gender Statistics
−6.5%
Access to anti-retroviral drugs, female (%)
Gender Statistics
+13.7%
Access to anti-retroviral drugs, male (%)
Gender Statistics
+20.3%
Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, female (per 100,000 female population)
Gender Statistics
–
Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, male (per 100,000 male population)
Gender Statistics
–
Total alcohol consumption per capita, female (liters of pure alcohol, projected estimates, female 15+ years of age)
World Development Indicators
0
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
World Development Indicators
0
Total alcohol consumption per capita, male (liters of pure alcohol, projected estimates, male 15+ years of age)
World Development Indicators
0
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
World Development Indicators
+1.1%
Prevalence of anemia among children (% of children ages 6-59 months)
World Development Indicators
+2.1%
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
World Development Indicators
+1.1%
Number of deaths ages 5-9 years
World Development Indicators
−5.8%
Number of deaths ages 10-14 years
World Development Indicators
0%
Number of deaths ages 15-19 years
World Development Indicators
−1.1%
Number of deaths ages 20-24 years
World Development Indicators
−1.9%
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
World Development Indicators
+6.6%
Number of infant deaths
World Development Indicators
−2.8%
Cause of death, by injury (% of total)
World Development Indicators
+1.7%
Number of under-five deaths
World Development Indicators
−3.4%
Cause of death, by non-communicable diseases (% of total)
World Development Indicators
−5.5%
Number of neonatal deaths
World Development Indicators
−5.8%
Probability of dying among children ages 5-9 years (per 1,000)
World Development Indicators
0%
Probability of dying among adolescents ages 10-14 years (per 1,000)
World Development Indicators
0%
Probability of dying among adolescents ages 15-19 years (per 1,000)
World Development Indicators
−6.3%
Probability of dying among youth ages 20-24 years (per 1,000)
World Development Indicators
−4.5%
Women's share of population ages 15+ living with HIV (%)
World Development Indicators
−2.7%
Prevalence of HIV, total (% of population ages 15-49)
World Development Indicators
0%
Mortality rate, under-5 (per 1,000 live births)
World Development Indicators
−3.6%
Mortality rate, under-5, female (per 1,000 live births)
World Development Indicators
−3.9%
Mortality rate, under-5, male (per 1,000 live births)
World Development Indicators
−3.3%
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
World Development Indicators
+16.3%
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
World Development Indicators
−17.1%
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%)
World Development Indicators
−15.5%
Mortality rate, neonatal (per 1,000 live births)
World Development Indicators
−4.3%
People using safely managed drinking water services, urban (% of urban population)
World Development Indicators
0%
People using safely managed drinking water services (% of population)
World Development Indicators
0%
Prevalence of HIV, female (% ages 15-24)
World Development Indicators
0%
Prevalence of HIV, male (% ages 15-24)
World Development Indicators
0%
Antiretroviral therapy coverage (% of people living with HIV)
World Development Indicators
+21.1%
Immunization, HepB3 (% of one-year-old children)
World Development Indicators
0%
Immunization, DPT (% of children ages 12-23 months)
World Development Indicators
0%
Immunization, measles (% of children ages 12-23 months)
World Development Indicators
−1%
Hospital beds (per 1,000 people)
World Development Indicators
+16.5%
Nurses and midwives (per 1,000 people)
World Development Indicators
−8.3%
Physicians (per 1,000 people)
World Development Indicators
+8.9%
Number of maternal deaths
World Development Indicators
0%
Lifetime risk of maternal death (1 in: rate varies by country)
World Development Indicators
+2.7%
Lifetime risk of maternal death (%)
World Development Indicators
−2.7%
Prevalence of anemia among pregnant women (%)
World Development Indicators
+0.7%
Prevalence of current tobacco use (% of adults)
World Development Indicators
0%
Prevalence of current tobacco use, females (% of female adults)
World Development Indicators
0%
Prevalence of current tobacco use, males (% of male adults)
World Development Indicators
+0.3%
Mortality rate attributed to household and ambient air pollution, age-standardized, female (per 100,000 female population)
World Development Indicators
–
Mortality rate attributed to household and ambient air pollution, age-standardized, male (per 100,000 male population)
World Development Indicators
–
Mortality rate attributed to household and ambient air pollution, age-standardized (per 100,000 population)
World Development Indicators
–
Pregnant women receiving prenatal care (%)
World Development Indicators
+5.3%
Exclusive breastfeeding (% of children under 6 months)
World Development Indicators
–
Births attended by skilled health staff (% of total)
World Development Indicators
0%
Low-birthweight babies (% of births)
World Development Indicators
+1.6%
Diabetes prevalence (% of population ages 20 to 79)
World Development Indicators
+23.7%
Prevalence of underweight, weight for age (% of children under 5)
World Development Indicators
−3.4%
Maternal mortality ratio (modeled estimate, per 100,000 live births)
World Development Indicators
0%
Diarrhea treatment (% of children under 5 who received ORS packet)
World Development Indicators
+873.3%
Prevalence of overweight, weight for height, female (modeled estimate, % of children under 5)
World Development Indicators
+1.1%
Prevalence of overweight, weight for height, male (modeled estimate, % of children under 5)
World Development Indicators
+0.9%
Prevalence of overweight, weight for height (modeled estimate, % of children under 5)
World Development Indicators
+1%
Mortality rate attributed to unintentional poisoning (per 100,000 population)
World Development Indicators
0%
Mortality rate attributed to unintentional poisoning, female (per 100,000 female population)
World Development Indicators
+8.3%
Mortality rate attributed to unintentional poisoning, male (per 100,000 male population)
World Development Indicators
−1.9%
People using safely managed sanitation services, urban (% of urban population)
World Development Indicators
0%
People using safely managed sanitation services (% of population)
World Development Indicators
0%
Prevalence of stunting, height for age, female (modeled estimate, % of children under 5)
World Development Indicators
0%
Prevalence of stunting, height for age, male (modeled estimate, % of children under 5)
World Development Indicators
0%
Prevalence of stunting, height for age (modeled estimate, % of children under 5)
World Development Indicators
0%
Suicide mortality rate, female (per 100,000 female population)
World Development Indicators
+25.9%
Suicide mortality rate, male (per 100,000 male population)
World Development Indicators
+4.4%
Suicide mortality rate (per 100,000 population)
World Development Indicators
+5.5%
Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (per 100,000 population)
World Development Indicators
–
Prevalence of wasting, weight for height (% of children under 5)
World Development Indicators
+2.9%
Prevalence of severe wasting, weight for height (% of children under 5)
World Development Indicators
+28.6%
Tuberculosis treatment success rate (% of new cases)
World Development Indicators
−1%
Tuberculosis case detection rate (%, all forms)
World Development Indicators
0%
Incidence of tuberculosis (per 100,000 people)
World Development Indicators
−9.1%
Newborns protected against tetanus (%)
World Development Indicators
0%
Current health expenditure (% of GDP)
World Development Indicators
+18.2%
Current health expenditure per capita (current US$)
World Development Indicators
−0.3%
Current health expenditure per capita, PPP (current international $)
World Development Indicators
+11.9%
External health expenditure (% of current health expenditure)
World Development Indicators
0
External health expenditure per capita (current US$)
World Development Indicators
0
External health expenditure per capita, PPP (current international $)
World Development Indicators
0
Domestic general government health expenditure (% of current health expenditure)
World Development Indicators
+0.5%
Domestic general government health expenditure (% of GDP)
World Development Indicators
+18.7%
Domestic general government health expenditure (% of general government expenditure)
World Development Indicators
−4%
Domestic general government health expenditure per capita (current US$)
World Development Indicators
+0.2%
Domestic general government health expenditure per capita, PPP (current international $)
World Development Indicators
+12.4%
Out-of-pocket expenditure (% of current health expenditure)
World Development Indicators
−7%
Out-of-pocket expenditure per capita (current US$)
World Development Indicators
−7.2%
Out-of-pocket expenditure per capita, PPP (current international $)
World Development Indicators
+4.1%
Domestic private health expenditure (% of current health expenditure)
World Development Indicators
−3.7%
Domestic private health expenditure per capita (current US$)
World Development Indicators
−3.9%
Domestic private health expenditure per capita, PPP (current international $)
World Development Indicators
+7.8%
Prevalence of undernourishment (% of population)
World Development Indicators
0%
Mortality rate, adult, female (per 1,000 female adults)
World Development Indicators
+1%
Mortality rate, adult, male (per 1,000 male adults)
World Development Indicators
−0.3%
Contraceptive prevalence, any modern method (% of married women ages 15-49)
World Development Indicators
−3.9%
Contraceptive prevalence, any method (% of married women ages 15-49)
World Development Indicators
+3.6%
Mortality rate, infant, female (per 1,000 live births)
World Development Indicators
−1.5%
Mortality rate, infant (per 1,000 live births)
World Development Indicators
−2.8%
Mortality rate, infant, male (per 1,000 live births)
World Development Indicators
−3.8%
Life expectancy at birth, female (years)
World Development Indicators
+2%
Life expectancy at birth, total (years)
World Development Indicators
+1.7%
Life expectancy at birth, male (years)
World Development Indicators
+1.3%
Survival to age 65, female (% of cohort)
World Development Indicators
−0.4%
Survival to age 65, male (% of cohort)
World Development Indicators
−0.3%
Population ages 75-79, female (% of female population)
World Development Indicators
+2.3%
Population ages 75-79, male (% of male population)
World Development Indicators
+1.9%
Population ages 80 and above, female (% of female population)
World Development Indicators
−0.2%
Population ages 80 and above, male (% of male population)
World Development Indicators
−4.8%
Completeness of death registration with cause-of-death information (%)
World Development Indicators
−37.9%
Number of female leprosy new cases
WHO
+50%
New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population
WHO
0
Number of non-autochthonous leprosy cases
WHO
+33.3%
New leprosy case detection rate per 1 000 000 population
WHO
+30.9%
Leprosy - Number of cases registered for treatment
WHO
+33.3%
Leprosy registered prevalence rate per 1 000 000 population
WHO
+30.9%
Number of new G2D leprosy cases
WHO
0
Leprosy - New leprosy cases with G2D rate per 1 000 000 population
WHO
0
Leprosy - Number of new leprosy cases among children (less than 15 years of age)
WHO
0
Number of new leprosy cases with G2D among children (less than 15 years of age)
WHO
0
Number of new leprosy cases
WHO
+33.3%
People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number)
WHO
+21.8%
Chronic hepatitis C (HCV) infected persons diagnosed (number)
WHO
+34.9%
Life expectancy at birth (years)
WHO
+1.2%
Healthy life expectancy (HALE) at birth (years)
WHO
+1.2%
Healthy life expectancy (HALE) at age 60 (years)
WHO
+4%
Life expectancy at age 60 (years)
WHO
+5.5%
Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
WHO
0%
Physical activity policies for activie societies
WHO
−1
Physical activity policies focused on active systems
WHO
0%
Number of imported cases of visceral leishmaniasis reported
WHO
0
Proportion of cities, municipalities and localities in regional Healthy City networks that are health-promoting
WHO
–
Overweight numbers among children under 5 years of age (thousands), model-based estimates
WHO
+0.7%
Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates
WHO
+1.1%
Stunting numbers among children under 5 years of age (millions), model-based estimates
WHO
0%
Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates
WHO
0%
Number of under-five deaths
WHO
−3.4%
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
WHO
−3.6%
Stillbirth rate (per 1000 total births)
WHO
0%
Number of deaths among children ages 5 to 9 years
WHO
−4.8%
Mortality rate among children ages 5 to 9 years (per 1000 children aged 5)
WHO
0%
Number of neonatal deaths
WHO
−5.8%
Neonatal mortality rate (per 1000 live births)
WHO
−4.3%
Number of deaths among children 5 to 14 years of age
WHO
−2.7%
Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
WHO
0%
Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
WHO
+5.7%
Number of infant deaths
WHO
−2.8%
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
WHO
−2.8%
Number of deaths among adolescents (10 to 19 years of age)
WHO
0%
Adolescent mortality rate (per 1 000 age specific cohort)
WHO
0%
Hepatitis B surface antigen (HBsAg) prevalence (%)
WHO
−0.1
Estimated number of people (all ages) living with HIV
WHO
+21.4%
Reported number of people receiving antiretroviral therapy
WHO
+17.4%
Reported number of children receiving antiretroviral therapy
WHO
+25%
Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
WHO
−16.7%
Estimated antiretroviral therapy coverage among people living with HIV (%)
WHO
−1.2%
Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%)
WHO
–
International Health Regulations core capacity scores, SPAR version, 2nd edition
WHO
0%
Reported number of human rabies deaths
WHO
0
Polio (Pol3) immunization coverage among 1-year-olds (%)
WHO
0%
Pertussis - number of reported cases
WHO
−88.4%
Total tetanus - number of reported cases
WHO
+2
Yellow fever - number of reported cases
WHO
0
Rubella - number of reported cases
WHO
+100%
Diphtheria - number of reported cases
WHO
0
Japanese encephalitis - number of reported cases
WHO
0
Mumps - number of reported cases
WHO
+2.9%
Congenital Rubella Syndrome - number of reported cases
WHO
0
Neonatal tetanus - number of reported cases
WHO
0
Measles - number of reported cases
WHO
−71.4%
Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
WHO
−1%
Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
WHO
−3.5%
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
WHO
+4.3%
Hib (Hib3) immunization coverage among 1-year-olds (%)
WHO
−3.1%
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
WHO
+1%
Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC)
WHO
0%
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
WHO
−3.1%
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
WHO
−3.1%
BCG immunization coverage among 1-year-olds (%)
WHO
0%
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC)
WHO
0%
Adopted written national policy on alcohol
WHO
–
Action Plan for implementation of alcohol policy
WHO
–
Alcoholic beverage legally defined
WHO
–
National legislation to prevent illegal alcohol
WHO
–
National drinking guidelines
WHO
–
National legislation to prevent illegal alcohol sales
WHO
–
Government monopoly on production
WHO
–
Government monopoly on retail sales
WHO
–
Detection of marketing infringements
WHO
–
Penalties for marketing infringements
WHO
–
Off-premise sales restrictions on days
WHO
–
Off-premise sales restrictions on hours
WHO
–
Off-premise sales restrictions on places
WHO
–
Off-premise sales restrictions on outlet density
WHO
–
On-premise sales restrictions on days
WHO
–
On-premise sales restrictions on hours
WHO
–
On-premise sales restrictions on places
WHO
–
On-premise sales restrictions on outlet density
WHO
–
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type
WHO
0
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
WHO
0%
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average
WHO
0%
Alcohol, tourist consumption (in litres of pure alcohol), three-year average
WHO
0
Alcohol, consumption of pure alcohol by type of beverage (%)
WHO
0%
Number of deaths ages 5-9 years, female
Health Nutrition and Population Statistics
−4.8%
Number of deaths ages 5-9 years, male
Health Nutrition and Population Statistics
−6.5%
Number of deaths ages 10-14 years, female
Health Nutrition and Population Statistics
0%
Number of deaths ages 10-14 years, male
Health Nutrition and Population Statistics
0%
Number of deaths ages 10-19 years
Health Nutrition and Population Statistics
−0.7%
Number of deaths ages 10-19 years, female
Health Nutrition and Population Statistics
0%
Number of deaths ages 10-19 years, male
Health Nutrition and Population Statistics
−1%
Number of deaths ages 15-19 years, female
Health Nutrition and Population Statistics
0%
Number of deaths ages 15-19 years, male
Health Nutrition and Population Statistics
−1.5%
Number of deaths ages 20-24 years, female
Health Nutrition and Population Statistics
0%
Number of deaths ages 20-24 years, male
Health Nutrition and Population Statistics
−2.7%
Number of infant deaths, female
Health Nutrition and Population Statistics
−2.5%
Number of infant deaths, male
Health Nutrition and Population Statistics
−3.1%
Number of under-five deaths, female
Health Nutrition and Population Statistics
−3.3%
Number of under-five deaths, male
Health Nutrition and Population Statistics
−3.5%
Number of stillbirths
Health Nutrition and Population Statistics
+1.6%
Probability of dying among children ages 5-9 years, female (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among children ages 5-9 years, male (per 1,000)
Health Nutrition and Population Statistics
−10%
Probability of dying among adolescents ages 10-14 years, female (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among adolescents ages 10-14 years, male (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among adolescents ages 10-19 years (per 1,000)
Health Nutrition and Population Statistics
−7.7%
Probability of dying among adolescents ages 10-19 years, female (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among adolescents ages 10-19 years, male (per 1,000)
Health Nutrition and Population Statistics
−5.9%
Probability of dying among adolescents ages 15-19 years, female (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among adolescents ages 15-19 years, male (per 1,000)
Health Nutrition and Population Statistics
−4.3%
Probability of dying among youth ages 20-24 years, female (per 1,000)
Health Nutrition and Population Statistics
0%
Probability of dying among youth ages 20-24 years, male (per 1,000)
Health Nutrition and Population Statistics
−3.4%
Stillbirth rate (per 1,000 total births)
Health Nutrition and Population Statistics
0%
Prevalence of hypertension, female (% of female adults ages 30-79)
Health Nutrition and Population Statistics
−1.4%
Prevalence of hypertension, male (% of male adults ages 30-79)
Health Nutrition and Population Statistics
+0.2%
Prevalence of hypertension (% of adults ages 30-79)
Health Nutrition and Population Statistics
−0.2%
Treatment for hypertension, female (% of female adults ages 30-79 with hypertension)
Health Nutrition and Population Statistics
+0.3%
Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Health Nutrition and Population Statistics
+1.2%
Treatment for hypertension (% of adults ages 30-79 with hypertension)
Health Nutrition and Population Statistics
+0.7%
Immunization, Hib3 (% of children ages 12-23 months)
Health Nutrition and Population Statistics
0%

Showing the 300 most recently updated of 711. Search all

Track Health in Kuwait

Get instant alerts when new health data is published.

Start today